Skip to content

Efficacy of Mulligan's mobilization with movement techniques on hemiplegic shoulder pain

Efficacy of Mulligan's mobilization with movement techniques on hemiplegic shoulder pain

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000039522
Enrollment
Unknown
Registered
2020-10-30
Start date
2020-11-01
Completion date
Unknown
Last updated
2021-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

control group:conventional rehabilitation treatments (CRT)
experimental group:CRT+MWM

Sponsors

Wuhan NO.1 Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Clinical diagnosis of hemiplegic shoulder pain. (2) Aged from 18 to 75 years,male and female. (3) The presence of HSP lasted more than one month. (4) The Brunnstrom Scale >= IV. (5) The mini-mental state examination (MMSE) score >= 24. (6) The visual analogue scale (VAS) score > 4. (7) Patients being able to provide informed consent.

Exclusion criteria

Exclusion criteria: (1) MRI examination showed severe rotator cuff or biceps tendon tear of the patients needing surgery. (2) Had a history of chronic shoulder pain or had undergone shoulder surgery before stroke. (3) Had complex regional pain syndrome after stroke. (4) Had severe sensory dysfunciton on the affected side. (5) Spasticity of 2 or more points as determined by the Modified Ashworth Scale (MAS).

Design outcomes

Primary

MeasureTime frame
visual analogue scale (VAS);

Secondary

MeasureTime frame
range of motion (ROM);Chinese version of the Constant-Murley questionnaire for shoulder pain and disability (CMS);Fugl-Meyer assessment scale of upper extremity (FMA-UE);

Countries

China

Contacts

Public ContactPei Ziwen

Wuhan NO.1 Hospital

165592510@qq.com+86 13296666644

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026